Cargando…

Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life study

BACKGROUND: Allergen-specific immunotherapy (AIT) is the only treatment able to change the natural course of allergic diseases. We aimed at investigating the clinical efficacy of SLITOR (Serbian registered vaccine for sublingual allergen specific immunotherapy). METHODS: 7–18 years old children with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Djuric-Filipovic, I., Caminati, Marco, Filipovic, D., Salvottini, C., Zivkovic, Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376712/ https://www.ncbi.nlm.nih.gov/pubmed/28392751 http://dx.doi.org/10.1186/s12948-017-0064-5

Ejemplares similares

The intriguing possibility of using probiotics in allergen-specific immunotherapy
por: Furci, Fabiana, et al.
Publicado: (2023)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2011)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2018)

Use of biologics in allergen immunotherapy
por: Pfützner, Wolfgang, et al.
Publicado: (2021)

Clinical evaluation of rush immunotherapy using house dust mite allergen in Japanese asthmatics
por: Uchida, Takahiro, et al.
Publicado: (2021)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Mechanisms of allergen-specific immunotherapy
por: Fujita, Hiroyuki, et al.
Publicado: (2012)

Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014)

Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
por: Akdis, Cezmi A, et al.
Publicado: (2015)

Immunotherapy – 2074. Tolerability of sublingual immunotherapy with tropical mite allergen vaccines using different dosing schedules in asthmatic children
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
por: Lins de Holanda Coelho, Gabriel, et al.
Publicado: (2022)

Expression of surface markers on the blood cells during the delayed asthmatic response to allergen challenge
por: Pelikan, Zdenek
Publicado: (2014)

Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study
por: Tat, Tugba S.
Publicado: (2018)

Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

Immunotherapy – 2073. Therapeutic effect of mite allergen vaccines by subcutaneous route in allergic Cuban asthmatic patients
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

486 Therapeutic Effect and Security in Asthmatics Adult Patients Treated with Dermatophagoides Pteronyssinus Allergen Sublingual Immunotherapy
por: Rodríguez, José, et al.
Publicado: (2012)

Allergen-Specific Immunotherapy in Food Anaphylaxis
por: Kerzl, Regina, et al.
Publicado: (2008)

Broad perspectives of allergen specific immunotherapy
por: Thomas, Wayne Robert
Publicado: (2017)

Allergen-Specific Immunotherapies for Food Allergy
por: Feuille, Elizabeth, et al.
Publicado: (2018)

Predicting Success of Allergen-Specific Immunotherapy
por: Zissler, Ulrich M., et al.
Publicado: (2020)

Novel vaccines for allergen-specific immunotherapy
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Safety of allergen‐specific immunotherapy in children
por: De Filippo, Maria, et al.
Publicado: (2022)

Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice
por: Siegle, Jessica S, et al.
Publicado: (2010)

Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy
por: Xu, Yingyang, et al.
Publicado: (2022)

The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
por: D’souza, Nishelle, et al.
Publicado: (2021)

Effect of Formaldehyde on Asthmatic Response to Inhaled Allergen Challenge
por: Ezratty, Véronique, et al.
Publicado: (2007)

Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics
por: Winkler, Carla, et al.
Publicado: (2014)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)
por: Scadding, Guy
Publicado: (2021)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Allergen-Specific Immunotherapy in Food Allergy: There Is Hope
por: Ring, Johannes
Publicado: (2008)

The placebo effect in allergen-specific immunotherapy trials
por: Narkus, Annemie, et al.
Publicado: (2013)

Allergen-specific immunotherapy in pediatric allergic asthma
por: Yukselen, Ayfer
Publicado: (2016)

Mechanisms and biomarkers of successful allergen-specific immunotherapy
por: López, Juan-Felipe, et al.
Publicado: (2022)

Food hypersensitivity in patients treated with specific allergen immunotherapy (SIT) for aeroallergens
por: Gocki, J, et al.
Publicado: (2013)

Allergen specific immunotherapy has no influence on standard chemistry and hematology laboratory parameters in clinical studies
por: Häfner, Dietrich, et al.
Publicado: (2014)

Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
por: Abu El‐Enin, Mohammed A., et al.
Publicado: (2022)

Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)

Diagnosis and Management of Allergic Rhinitis in Asthmatic Children
por: Tenero, Laura, et al.
Publicado: (2023)

Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
por: Caminati, Marco, et al.
Publicado: (2020)

Nanoparticle–allergen complexes for allergen immunotherapy
por: Di Felice, Gabriella, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s6j9qvbqo207jna8gp7oo0jlkm